DD265899A5 - Verfahren zur herstellung neuer thieno-triazolo-1,4-diazepino-2-carbonsaeuren - Google Patents

Verfahren zur herstellung neuer thieno-triazolo-1,4-diazepino-2-carbonsaeuren Download PDF

Info

Publication number
DD265899A5
DD265899A5 DD86311011A DD31101186A DD265899A5 DD 265899 A5 DD265899 A5 DD 265899A5 DD 86311011 A DD86311011 A DD 86311011A DD 31101186 A DD31101186 A DD 31101186A DD 265899 A5 DD265899 A5 DD 265899A5
Authority
DD
German Democratic Republic
Prior art keywords
triazolo
halogen
carbon atoms
thieno
general formula
Prior art date
Application number
DD86311011A
Other languages
German (de)
English (en)
Inventor
Karl-Heinz Weber
Gerhard Walther
Albrecht Harreus
Jorge Casals-Stenzel
Gojki Muacevic
Wolfgang Troeger
Original Assignee
�������@������������@��k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by �������@������������@��k�� filed Critical �������@������������@��k��
Publication of DD265899A5 publication Critical patent/DD265899A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30—Hetero atoms other than halogen
    • C07D333/36—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD86311011A 1985-01-25 1986-01-23 Verfahren zur herstellung neuer thieno-triazolo-1,4-diazepino-2-carbonsaeuren DD265899A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853502392 DE3502392A1 (de) 1985-01-25 1985-01-25 Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen

Publications (1)

Publication Number Publication Date
DD265899A5 true DD265899A5 (de) 1989-03-15

Family

ID=6260695

Family Applications (3)

Application Number Title Priority Date Filing Date
DD86311011A DD265899A5 (de) 1985-01-25 1986-01-23 Verfahren zur herstellung neuer thieno-triazolo-1,4-diazepino-2-carbonsaeuren
DD86286429A DD263063A5 (de) 1985-01-25 1986-01-23 Verfahren zur herstellung von neuen thieno-triazolo-1,4-diazepino-2-carbonsaeureamide
DD86311014A DD265799A5 (de) 1985-01-25 1986-01-23 Verwendung von neuen thieno-triazolo-1,4-diazepino-2-carbonsaeureamiden

Family Applications After (2)

Application Number Title Priority Date Filing Date
DD86286429A DD263063A5 (de) 1985-01-25 1986-01-23 Verfahren zur herstellung von neuen thieno-triazolo-1,4-diazepino-2-carbonsaeureamide
DD86311014A DD265799A5 (de) 1985-01-25 1986-01-23 Verwendung von neuen thieno-triazolo-1,4-diazepino-2-carbonsaeureamiden

Country Status (28)

Country Link
US (3) US4968794A (sh)
EP (1) EP0194416B1 (sh)
JP (2) JPH0633278B2 (sh)
KR (1) KR920010711B1 (sh)
AT (1) ATE42556T1 (sh)
AU (1) AU584663B2 (sh)
CA (1) CA1269373A (sh)
CS (1) CS254992B2 (sh)
CZ (1) CZ410791A3 (sh)
DD (3) DD265899A5 (sh)
DE (2) DE3502392A1 (sh)
DK (2) DK165323C (sh)
ES (3) ES8704949A1 (sh)
FI (1) FI86851C (sh)
GR (1) GR860189B (sh)
HK (1) HK75792A (sh)
HU (2) HU195821B (sh)
IE (1) IE58728B1 (sh)
IL (1) IL77702A (sh)
MX (1) MX9203258A (sh)
NO (2) NO164029C (sh)
NZ (1) NZ214926A (sh)
PL (1) PL144948B1 (sh)
PT (1) PT81898B (sh)
SG (1) SG44292G (sh)
SU (1) SU1402265A3 (sh)
YU (2) YU44280B (sh)
ZA (1) ZA86542B (sh)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
EP0230942B1 (de) * 1986-01-21 1992-04-29 Boehringer Ingelheim Kg Thieno-1,4-diazepine
DE3610848A1 (de) * 1986-04-01 1987-10-15 Boehringer Ingelheim Kg Neue 1,4-diazepine
PH30676A (en) * 1986-07-22 1997-09-16 Boehringer Ingelhein Kg Hetrazepine compounds which have useful pharmaceutical utility
DE3745135C2 (de) * 1986-10-21 1999-05-12 Korth Ruth Verwendung von hydrophilen Triazolothieno-diazepinen zur Behandlung von Arteriosklerose
EP0268242B1 (en) * 1986-11-17 1992-03-18 Yoshitomi Pharmaceutical Industries, Ltd. Paf-antagonistic thienotriazolodiazepine compounds and pharmaceutical uses thereof
DE3725130C2 (de) * 1987-07-29 1996-12-12 Boehringer Ingelheim Kg Tritium-oder ·1··4·C-markiertes 4-(2-Chlorphenyl)-9-methyl-2-[3-(4-morpholinyl)-3-propanon-1-yl]-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin, Verfahren zu deren Herstellung und deren Verwendung als Radiorezeptorassay sowie zu diagnostischen Zwecken
US5895785A (en) * 1987-10-20 1999-04-20 Ruth Korth Treatment and prevention of disorders mediated by LA-paf or endothelial cells
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
CA1324863C (en) * 1988-01-30 1993-11-30 Minoru Moriwaki Thienotriazolodiazepine compounds and pharmaceutical uses thereof
EP0338993A1 (en) * 1988-04-21 1989-10-25 Sandoz Ag 6-Aryl-substituted-4h-thieno[2,3-e][1,2,4]triazolo [3,4-c][1,4]diazepines
EP0345931B1 (en) * 1988-04-27 1993-01-20 Schering Corporation Certain paf antagonist/antihistamine combinations and methods
US5334592A (en) * 1988-04-27 1994-08-02 Schering Corporation Certain PAF antagonist antihistamine combinations and methods
CA1322367C (en) * 1988-05-17 1993-09-21 Yoshitomi Pharmaceutical Industries Ltd. Thienotriazolodiazepine compounds and pharmaceutical uses thereof
US5221671A (en) * 1988-10-31 1993-06-22 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
RU2117670C1 (ru) * 1988-10-31 1998-08-20 Эйсай Ко., Лтд. Производные триазоло[1,4]диазепина и способы их получения
US5468740A (en) * 1988-10-31 1995-11-21 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
US5382579A (en) * 1988-10-31 1995-01-17 Eisai Co., Ltd. Triazolo-1,4-diazepine derivatives and their use in pharmaceuticals
FI95708C (fi) * 1988-10-31 1996-03-11 Eisai Co Ltd Analogiamenetelmä 1,4-diatsepiinijohdannaisen ja sen farmaseuttisesti sopivan suolan valmistamiseksi
US5304553A (en) * 1988-10-31 1994-04-19 Eisai Co., Ltd. 1,4-diazepine derivative and its pharmaceutical use
EP0387613A1 (de) * 1989-03-03 1990-09-19 Boehringer Ingelheim Kg Neue Thienodiazepine
DE4010528A1 (de) * 1990-04-02 1991-10-17 Boehringer Ingelheim Kg Praeparativ chromatographisches trennverfahren zur herstellung enantiomerenreiner hetrazepine
EP0532512B1 (en) * 1990-05-31 1996-12-11 Allergan, Inc. Use of platelet activating factor antagonists as anti-pruritic agents
DE4027470A1 (de) * 1990-08-30 1992-03-05 Boehringer Ingelheim Kg Neue hetrazepinoide amide
DE4128579A1 (de) * 1991-08-28 1993-03-04 Boehringer Ingelheim Kg Verwendung von 4-(2-chlorphenyl)-9-methyl-2-(3(4-morpholinyl)-3-propanon-1-y1)-6h-thieno-(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepin zur behandlung der allergischen rhinitis
ES2181665T3 (es) * 1991-11-04 2003-03-01 Ruth-Maria Korth Tratamiento y prevencion de enfermedades mentales, acompañadas por unos elevados niveles de liso paf, con los antagonistas de paf.
TW219935B (sh) * 1991-12-25 1994-02-01 Mitsubishi Chemicals Co Ltd
DE4200619A1 (de) * 1992-01-13 1993-07-15 Boehringer Ingelheim Kg Verwendung von 4-(2-chlorphenyl)-9-methyl-2-/3(4-morpholinyl)-3-propanon-1-yl/-6h-thieno-/3,2-f//1,2,4/ triazolo/4,3-a//1,4/diazepin zur behandlung der dysmenorrhes
GB9207645D0 (en) * 1992-04-08 1992-05-27 Smithkline Beecham Corp Methods
WO1994004537A2 (en) * 1992-08-20 1994-03-03 Cytomed, Inc. Dual functional anti-inflammatory and immunosuppressive agents
US5288514A (en) * 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5302590A (en) * 1992-12-18 1994-04-12 Hoffmann-La Roche Inc. Compounds useful as dual antagonists of platelet activating factor and leukotriene D4
KR970707131A (ko) * 1994-11-08 1997-12-01 다께다 구니오 티에노피리딘 또는 티에노피리미딘 유도체 및 그의 용도(thienopyridine or thienopyrimidine derivatives and their use)
WO1998058930A1 (fr) 1997-06-25 1998-12-30 Nikken Chemicals Co., Ltd. Composes de triazolo-1,4-diazepine et composition medicinale les contenant
NZ543741A (en) 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US7223167B2 (en) * 2005-04-01 2007-05-29 Cnh America Llc Anti-wind wiper with adjustable extension
US8026377B2 (en) 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US9638493B2 (en) 2011-11-26 2017-05-02 Orval E. Bowman Pointing devices, apparatus, systems and methods for high shock environments
KR20230109692A (ko) 2020-11-16 2023-07-20 베링거 인겔하임 인터내셔날 게엠베하 혈소판 활성화 인자 수용체 길항제로서의 시클로펜타티오펜 카복스아미드 유도체
US11992494B2 (en) 2021-12-22 2024-05-28 Boehringer Ingelheim International Gmbh Cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12303A (en) * 1973-02-08 1979-01-16 Hoffmann La Roche Thienotriazolodiazepine derivatives
DE2503235A1 (de) * 1975-01-27 1976-07-29 Boehringer Sohn Ingelheim Neues verfahren zur herstellung von 8-brom-thieno-triazolo-1,4-diazepinen
US4201712A (en) * 1975-07-16 1980-05-06 Boehringer Ingelheim Gmbh Process for preparation of 6-aryl-4H-s-triazolo-[3,4-c]-thieno-[2,3-e]-1,4-diazepines
AU518438B2 (en) * 1978-04-26 1981-10-01 Boehringer Ingelheim International Gmbh Substituted 6-aryl-4h-s-triazolo-3,4-c-thieno-2,3-e-1,4-diazepines
AU520063B2 (en) * 1978-07-13 1982-01-14 Boehringer Ingelheim International Gmbh Substituted 4h-s-triazolo(3,4-c)thieno(2,3-e)1,4-diazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
DE3502392A1 (de) * 1985-01-25 1986-07-31 Boehringer Ingelheim KG, 6507 Ingelheim Neue thieno-triazolo-1,4-diazepino-2- carbonsaeureamide, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen
EP0230942B1 (de) * 1986-01-21 1992-04-29 Boehringer Ingelheim Kg Thieno-1,4-diazepine
DE3878833T2 (de) * 1987-05-28 1993-06-09 Yoshitomi Pharmaceutical Thieno(triazolo)diazepinverbindungen, und medizinische verwendung derselben.
US4959361A (en) * 1987-12-18 1990-09-25 Hoffmann-La Roche Inc. Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists
US4914096A (en) * 1988-04-21 1990-04-03 Sandoz Pharmaceuticals Corp. 6-aryl-substituted-4H-thieno(2,3-e)(1,2,4)triazolo(3,4-c)(1,4)diazepines

Also Published As

Publication number Publication date
DE3502392A1 (de) 1986-07-31
ES8802523A1 (es) 1988-07-16
FI86851C (fi) 1992-10-26
DK36786D0 (da) 1986-01-24
CS254992B2 (en) 1988-02-15
PT81898A (de) 1986-02-01
HUT40441A (en) 1986-12-28
NO166646C (no) 1991-08-21
NO166646B (no) 1991-05-13
SU1402265A3 (ru) 1988-06-07
DK165323C (da) 1993-03-29
ES8704949A1 (es) 1987-04-16
DK46292D0 (da) 1992-04-06
JPH0633278B2 (ja) 1994-05-02
IE860209L (en) 1986-07-25
US4968794A (en) 1990-11-06
DD265799A5 (de) 1989-03-15
GR860189B (en) 1986-05-26
ES551198A0 (es) 1987-04-16
DK165323B (da) 1992-11-09
IE58728B1 (en) 1993-11-03
FI860296A0 (fi) 1986-01-22
YU46049B (sh) 1992-12-21
PL257602A1 (en) 1987-05-04
DK36786A (da) 1986-07-26
ES557343A0 (es) 1988-06-01
FI86851B (fi) 1992-07-15
EP0194416B1 (de) 1989-04-26
NZ214926A (en) 1989-04-26
NO164029C (no) 1990-08-22
ES8802426A1 (es) 1988-06-01
CZ410791A3 (en) 1993-04-14
HU195821B (en) 1988-07-28
DE3663028D1 (en) 1989-06-01
YU79987A (en) 1988-06-30
ES557344A0 (es) 1988-07-16
ZA86542B (en) 1987-09-30
YU44280B (en) 1990-04-30
CA1269373A (en) 1990-05-22
NO894640L (no) 1986-07-28
ATE42556T1 (de) 1989-05-15
AU584663B2 (en) 1989-06-01
EP0194416A1 (de) 1986-09-17
MX9203258A (es) 1992-07-01
US5082839A (en) 1992-01-21
KR920010711B1 (ko) 1992-12-14
YU7886A (en) 1987-10-31
NO855260L (no) 1986-07-28
JPS61176591A (ja) 1986-08-08
US5155103A (en) 1992-10-13
HK75792A (en) 1992-10-09
PT81898B (pt) 1988-05-27
DD263063A5 (de) 1988-12-21
NO894640D0 (no) 1989-11-22
FI860296A (fi) 1986-07-26
KR860005822A (ko) 1986-08-13
HU193624B (en) 1987-11-30
NO164029B (no) 1990-05-14
PL144948B1 (en) 1988-07-30
JPH02191281A (ja) 1990-07-27
AU5272886A (en) 1986-07-31
JPH0651704B2 (ja) 1994-07-06
SG44292G (en) 1992-09-04
DK46292A (da) 1992-04-06
IL77702A (en) 1989-02-28

Similar Documents

Publication Publication Date Title
DD265899A5 (de) Verfahren zur herstellung neuer thieno-triazolo-1,4-diazepino-2-carbonsaeuren
DE3724164A1 (de) Neue 1,4-benzodiazepine, ihre herstellung und verwendung
CH648559A5 (de) Theophyllinderivate und verfahren zu deren herstellung.
DE2225149A1 (de) Neue Oxofurylesterdenvate von Penicillin und Cephalosporin
DE2040510A1 (de) Neue Azepin-Derivate
DE2320040A1 (de) Verfahren zur herstellung von 7acylamino-desacetoxy-cephalosporansaeureester
CH628040A5 (de) Verfahren zur herstellung neuer 4-hydroxy-2h-naphtho(2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxyde.
DE2556045C2 (sh)
CH497436A (de) Verfahren zur Herstellung von Benzodiazepin-Derivaten
DE1670248A1 (de) Verfahren zur Herstellung von substituierten Isothiazolen
DE3037896A1 (de) Verfahren zur herstellung von dioxopenicillanverbindungen
AT339294B (de) Verfahren zur herstellung von 4-(5- oder 7-)-benzoylindolin-2-onen
DE3909012A1 (de) Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen
DD146046A5 (de) Verfahren zur herstellung von auronderivaten
DE1770421C3 (de) Verfahren zur Herstellung von 1,3-Dihydro-2H-1,4-benzodiazepin-2-onderivaten
DE2439454A1 (de) Verfahren zur herstellung von chinazolinon-derivaten
DE3624779A1 (de) Verfahren zur herstellung von thieno-triazolo-1,4-diazepino-2- carbonsaeureamiden
DE1545805B2 (de) Verfahren zur Herstellung von Benzothiazocln-Derlvaten
DE1620308A1 (de) Verfahren zur Herstellung von neuen heterocyclischen Verbindungen
DE955861C (de) Verfahren zur Herstellung von Imidazolderivaten
AT345843B (de) Verfahren zur herstellung neuer 4-hydroxy-2h- naphtho- (2,1-e)-1,2-thiazin-3-carboxamid-1,1-dioxide und deren salze
EP0338494B1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren
AT223196B (de) Verfahren zur Herstellung von neuen, 2-araliphatischen 3,4-Dihydro-1,2,4-benzothiadiazin-1,1-dioxyden
CH639963A5 (en) Process for the preparation of thiazole derivatives
DE1545590A1 (de) Neue Penicilline und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee